XLVS.L vs. GNOM.L
XLVS.L (Invesco Health Care S&P US Select Sector UCITS ETF Acc) and GNOM.L (Global X Genomics & Biotechnology UCITS ETF) are both Health & Biotech Equities funds - XLVS.L tracks the S&P® Select Sector Capped 20% Health Care Index while GNOM.L tracks the Global X Genomics & Biotechnology UCITS ETF. Both are passively managed. Over the past 3 years, XLVS.L returned 8.05%/yr vs 4.58%/yr for GNOM.L. A 0.50 correlation means they provide meaningful diversification when combined. XLVS.L charges 0.14%/yr vs 0.50%/yr for GNOM.L.
Performance
XLVS.L vs. GNOM.L - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, XLVS.L achieves a 2.92% return, which is significantly lower than GNOM.L's 22.10% return.
XLVS.L
- 1D
- 0.59%
- 1M
- 4.29%
- 6M
- 1.82%
- YTD
- 2.92%
- 1Y
- 21.48%
- 3Y*
- 8.05%
- 5Y*
- 5.72%
- 10Y*
- 9.42%
GNOM.L
- 1D
- -0.17%
- 1M
- 11.69%
- 6M
- 15.71%
- YTD
- 22.10%
- 1Y
- 62.79%
- 3Y*
- 4.58%
- 5Y*
- —
- 10Y*
- —
XLVS.L vs. GNOM.L - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
XLVS.L Invesco Health Care S&P US Select Sector UCITS ETF Acc | 2.92% | 14.78% | 2.15% | 1.56% | -2.62% | 6.23% |
GNOM.L Global X Genomics & Biotechnology UCITS ETF | 22.10% | 19.30% | -17.99% | -5.77% | -37.21% | -8.59% |
Correlation
The correlation between XLVS.L and GNOM.L is 0.51, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.51 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.48 |
Correlation (All Time) Calculated using the full available price history since Nov 2, 2021 | 0.50 |
The correlation between XLVS.L and GNOM.L has been stable across timeframes, ranging from 0.48 to 0.51 - a consistent structural relationship.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
XLVS.L vs. GNOM.L — Risk / Return Rank
XLVS.L
GNOM.L
XLVS.L vs. GNOM.L - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Invesco Health Care S&P US Select Sector UCITS ETF Acc (XLVS.L) and Global X Genomics & Biotechnology UCITS ETF (GNOM.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| XLVS.L | GNOM.L | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.75 | ||
| Sortino ratioReturn per unit of downside risk | -0.82 | ||
| Omega ratioGain probability vs. loss probability | 1.24 | 1.34 | -0.10 |
| Calmar ratioReturn relative to maximum drawdown | 2.05 | 3.35 | -1.30 |
| Martin ratioReturn relative to average drawdown | 5.02 | 9.16 | -4.14 |
Loading charts...
Drawdowns
XLVS.L vs. GNOM.L - Drawdown Comparison
The maximum XLVS.L drawdown since its inception was -26.88%, smaller than the maximum GNOM.L drawdown of -69.32%. Use the drawdown chart below to compare losses from any high point for XLVS.L and GNOM.L.
Loading charts...
Drawdown Indicators
| XLVS.L | GNOM.L | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -26.88% | -69.32% | +42.44% |
Max Drawdown (1Y)Largest decline over 1 year | -10.45% | -18.91% | +8.46% |
Max Drawdown (3Y)Largest decline over 3 years | -17.56% | -44.77% | +27.21% |
Max Drawdown (5Y)Largest decline over 5 years | -17.56% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -26.88% | — | — |
Current DrawdownCurrent decline from peak | -3.37% | -37.11% | +33.74% |
Average DrawdownAverage peak-to-trough decline | -4.52% | -47.16% | +42.64% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.27% | 6.92% | -2.65% |
Volatility
XLVS.L vs. GNOM.L - Volatility Comparison
The current volatility for Invesco Health Care S&P US Select Sector UCITS ETF Acc (XLVS.L) is 6.06%, while Global X Genomics & Biotechnology UCITS ETF (GNOM.L) has a volatility of 8.41%. This indicates that XLVS.L experiences smaller price fluctuations and is considered to be less risky than GNOM.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| XLVS.L | GNOM.L | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.06% | 8.41% | -2.35% |
Volatility (6M)Calculated over the trailing 6-month period | 11.63% | 22.18% | -10.55% |
Volatility (1Y)Calculated over the trailing 1-year period | 15.68% | 29.87% | -14.19% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 14.92% | 33.11% | -18.19% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 15.57% | 33.11% | -17.54% |
XLVS.L vs. GNOM.L - Expense Ratio Comparison
XLVS.L has a 0.14% expense ratio, which is lower than GNOM.L's 0.50% expense ratio.
Dividends
XLVS.L vs. GNOM.L - Dividend Comparison
Neither XLVS.L nor GNOM.L has paid dividends to shareholders.
Frequently Asked Questions
XLVS.L and GNOM.L have a correlation of 0.51, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, XLVS.L is cheaper at 0.14% per year. The better choice depends on whether you care most about return, fees, risk, or income.
XLVS.L is cheaper with a 0.14% expense ratio, compared with 0.50% for GNOM.L.
XLVS.L tracks S&P® Select Sector Capped 20% Health Care Index, while GNOM.L tracks Global X Genomics & Biotechnology UCITS ETF. They also come from different issuers: Invesco and Global X. Their fees differ too: 0.14% for XLVS.L and 0.50% for GNOM.L.
Find the right allocation for XLVS.L and GNOM.L
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer